N Vochelle
Overview
Explore the profile of N Vochelle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
195
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Planes A, Vochelle N
Orthopedics
. 2014 May;
20:18-21.
PMID: 24826620
ABSTRACTA prospective, randomized, double-blind trial was performed in total hip replacement patients to document the risk of deep vein thrombosis (DVT) after hospital discharge, and to assess the efficacy of...
2.
Planes A, Vochelle N, Gonzalez de Suso M, Claracq J
Rev Esp Anestesiol Reanim
. 2001 Jul;
48(6):258-63.
PMID: 11446940
Objective: Bemiparin is a new second generation low molecular weight heparin with a molecular weight of 3,600 daltons and an anti-Xa/anti-IIa ratio greater than 8. The aim of this study...
3.
Planes A, Vochelle N, Fafola M
Semin Thromb Hemost
. 1999 Nov;
25 Suppl 3:73-7.
PMID: 10549719
Knee replacement surgery is associated with a high risk of venous thromboembolic complications, and the risk appears to be highest during the 7 days following surgery. Meta-analysis of a number...
4.
Planes A, Samama M, Lensing A, Buller H, Barre J, Vochelle N, et al.
Thromb Haemost
. 1999 May;
81(1):22-5.
PMID: 10348714
Consecutive patients undergoing total hip replacement in 43 centres were randomly assigned to receive blindly either enoxaparin (40 mg) or tinzaparin (4,500 anti-Factor IU Xa), as once daily subcutaneous injections....
5.
Planes A, Vochelle N, Fagola M, Bellaud M
Blood Coagul Fibrinolysis
. 1998 Nov;
9(6):499-505.
PMID: 9819000
Low-molecular-weight heparins (LMWHs) have been shown to be effective in the prevention of deep vein thrombosis (DVT) after major orthopaedic surgery, such as total hip replacement (THR). The efficacy and...
6.
Planes A, Vochelle N, Darmon J
Chest
. 1998 Sep;
114(2 Suppl Evidence):125S-129S.
PMID: 9726707
No abstract available.
7.
Detournay B, Planes A, Vochelle N, Fagnani F
Pharmacoeconomics
. 1997 Dec;
13(1 Pt 1):81-9.
PMID: 10175988
The risk of late-occurring deep vein thrombosis and pulmonary embolism after total hip replacement persists for at least 3 weeks after hospital discharge. Recent clinical trials have demonstrated that prolonged...
8.
Planes A, Vochelle N
Orthopedics
. 1997 Feb;
20 Suppl:18-21.
PMID: 9048403
A prospective, randomized, double-blind trial was performed in total hip replacement patients to document the risk of deep vein thrombosis (DVT) after hospital discharge, and to assess the efficacy of...
9.
Planes A, Vochelle N, Darmon J, Fagola M, Bellaud M, Huet Y
Lancet
. 1996 Jul;
348(9022):224-8.
PMID: 8684199
Background: The risk of deep-vein thrombosis (DVT) and pulmonary embolism after total hip replacement (THR) surgery may persist after hospital discharge, but the extent of the risk is not known....
10.
Planes A, Vochelle N, Darmon J, Fagola M, Bellaud M, Compan D, et al.
Drugs
. 1996 Jan;
52 Suppl 7:47-54.
PMID: 9042560
Although venous thromboembolism has occasionally been reported after hospital discharge in patients who have undergone total hip replacement (THR), this risk has not been fully quantified and the usefulness of...